ArticleJournal of the American Heart Association2021
Methamphetamine-Associated Heart Failure Hospitalizations Across the United States: Geographic and Social Disparities.
Article in Journal of the American Heart Association, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 29 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
29 citing papers in PubMed, 44 citations in OpenAlex.
- US drug overdose deaths involving stimulants without opioids continued to rise in 2024.Addictive behaviors reports · 2026Article
- Brixadi for Stimulant Use Disorder: Evolving Pharmacologic Considerations and Clinical Implications.Advances in therapy · 2026Review
- Development and Validation of a Markov Microsimulation Model for the Economic Evaluation of Methamphetamine-Associated Heart Failure in the United States.Journal of the American Heart Association · 2026Article
- Methamphetamine Use Among Adult Patients Presenting With Acute Coronary Syndrome: A Single-Center Retrospective Cohort Study.Journal of the American Heart Association · 2026Article
- Rural community peer partnerships for improving methamphetamine -associated heart failure screening and engagement in cardiology care (PEER-Heart): Study protocol.Drug and alcohol dependence reports · 2026Article
- Supporting Patients With Stimulant Use Disorder During and After Hospitalization With a Mobile App-based Contingency Management Intervention: A Feasibility and Acceptability Study.Journal of addiction medicine · 2025Article
- Methamphetamine-Associated Heart Failure: A Patient-Centered Approach to Care.JACC. Case reports · 2025Article
- Trends in stimulant-related emergency department visits among adults in California, 2017-2021.The American journal of emergency medicine · 2025Article
- Hospitalized patients and stimulant use-associated heart failure: importance of ejection fraction and related risk factors.Frontiers in cardiovascular medicine · 2025Article
- Ischemic Evaluation in New-Onset Methamphetamine-Associated Heart Failure.Journal of the American Heart Association · 2024Article
- Community-Based Outreach for People Living With Methamphetamine-Associated Cardiomyopathy.JACC. Case reports · 2024Article
- U.S. trends in methamphetamine-involved psychiatric hospitalizations in the United States, 2015-2019.Drug and alcohol dependence · 2024Article
- Precision Phenotyping of Heart Failure in People with HIV: Early Insights and Challenges.Current heart failure reports · 2024Review
- Cardiomyopathy-Associated Hospital Admissions Among Methamphetamine Users: Geographical and Social Disparities.JACC. Advances · 2024Article
- Facing a Tsunami: Methamphetamine Heart Failure Demands Novel Approaches.JACC. Advances · 2024Article
- Cardiomyopathy in Patients With Acute Ischemic Stroke and Methamphetamine Use: Relevance for Cardioembolic Stroke and Outcome.Journal of the American Heart Association · 2024Article
- Characteristics and co-morbidities associated with hospital discharges for opioid and methamphetamine co-use, United States 2016-2019.Drug and alcohol dependence reports · 2024Article
- Temporal Trends in Substance Use and Cardiovascular Disease-Related Mortality in the United States.Journal of the American Heart Association · 2024Article
- Trends and patterns in pulmonary arterial hypertension-associated hospital admissions among methamphetamine users: a decade-long study.Frontiers in cardiovascular medicine · 2024Article
- People with lived and living experience of methamphetamine use and admission to hospital: what harm reduction do they suggest needs to be addressed?Health promotion and chronic disease prevention in Canada : research, policy and practice · 2023Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors at 1 institution in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background Although methamphetamine abuse is associated with the development of heart failure (HF), nationwide data on methamphetamine-associated HF (MethHF) hospitalizations are limited. This study evaluates nationwide HF hospitalizations associated with substance abuse to better understand MethHF prevalence trends and the clinical characteristics of those patients. Methods and Results This cross-sectional period-prevalence study used hospital discharge data from the National Inpatient Sample to identify adult primary HF hospitalizations with a secondary diagnosis of abuse of methamphetamines, cocaine, or alcohol in the United States from 2002 to 2014. All 2014 MethHF admissions were separated by regional census division to evaluate geographical distribution. Demographics, payer information, and clinical characteristics of MethHF hospitalizations were compared with all other HF hospitalizations. Total nationwide MethHF hospitalizations increased from 547 in 2002 to 6625 in 2014 with a predominance on the West Coast. Methamphetamine abuse was slightly more common among primary HF hospitalizations compared with all-cause hospitalizations (7.4 versus 6.4 per 1000; Cohen
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.